Ticagrelor

SKU T0179-1 mL * 10 mM (in DMSO) Category Brand:

Price range: 48 CAD through 317 CAD

Products Details

Product Description

– Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU).

Web ID

– T0179

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C23H28F2N6O4S

References

– VAN Giezen JJ, et al. J Thromb Haemost, 2009, 7(9), 1556-1565.

CAS Number

– 274693-27-5

Molecular Weight

– C23H28F2N6O4S

Compound Purity

– 0.9977

SMILES

– CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1

Target

– Endogenous Metabolite

Pathway

– GPCR/G Protein|||Neuroscience|||Metabolism

Product type

– Small Compound

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Wishlist
Recently Viewed
Categories

Request Data Sheet / Safty Data Sheet

Please enable JavaScript in your browser to complete this form.
=

Price Request

Please enable JavaScript in your browser to complete this form.
=

Compare Products (0 Products)
document.addEventListener('elementor/popup/show', function() { if (typeof turnstile !== 'undefined') { document.querySelectorAll('.cf-turnstile').forEach(function(el) { if (!el.dataset.rendered) { turnstile.render(el); el.dataset.rendered = true; } }); } });